What Happened?
, -based Generate Biomedicines Appointed Jason Silvers as Chief Financial Officer
About the Company
Generate Biomedicines is the first drug generation company, pioneering a machine learning-powered generative biology platform with the ability to generate new drugs on demand across a wide range of biologic modalities. The platform can drastically improve the speed at which targets and therapeutics are identified and validated, the specificity of target engagement by generated proteins, and the cost of identifying and developing clinical candidates. The company`s platform represents a potentially fundamental shift in what`s possible in the field of therapeutic development, addressing key challenges of drug discovery and drastically expanding the available search space for novel biomedicines. Generate Biomedicines was founded by Flagship Pioneering after two years of foundational research in its Labs unit and launched in 2020.
About the Person
Jason Silvers is Chief Financial Officer at Generate Biomedicines. Previously, Jason held various senior HR leadership roles in the industry.
Info Source
News
Short Profile